Skip to Main Content
James Galvin

James E Galvin, M.D., M.P.H.

Department:

Neurology

Division:

Cognitive Neurology

James Galvin

Roles

  • Professor of Neurology
  • Chief, Division of Cognitive Neurology
  • Director, Comprehensive Center for Brain Health
  • Director, Lewy Body Dementia Research Center of Excellence
  • Biography

    James E. Galvin, M.D., M.P.H. is Professor of Neurology and Psychiatry & Behavioral Sciences at the University of Miami Miller School of Medicine. He is Division Chief for Cognitive Neurology, Founding Director of the Comprehensive Center for Brain Health, and Director and Principal Investigator of the Lewy Body Dementia Research Center of Excellence. Dr. Galvin has authored over 325 scientific publications (h-index=66) and 3 textbooks on healthy brain aging, cognitive health, Alzheimer’s disease, Lewy Body dementia, and related disorders. Dr. Galvin is principal investigator on 9 active NIH grants and has received over $100 Million in research funding from the National Institutes of Health, Disease Associations, Private and Family Foundations.
  • Education & Training

    Education

    • 2005
      Saint Louis University, St Louis, MO
      MPH, Epidemiology
    • 1992
      Rutgers University - New Jersey Medical School, Newark, NJ
      MD, Medicine
    • 1991
      Rutgers University, New Brunswick, NJ
      MS, Nutrition
    • 1986
      New York University, New York, NY
      BA, Chemistry

    Post Graduate Training

    • 1997
      University of Pennsylvania, Philadelphia, PA
      Post-Doctoral Fellowship, Neurodegenerative Disease
    • 1996
      Hahnemann University, Philadelphia
      Residency, Neurology - Chief Resident
    • 1995
      Thomas Jefferson University, Philadelphia, PA
      Residency, Neurology
    • 1993
      Hackensack University Hospital, Hackensack, NJ
      Internship, Internal Medicine

    Licensures and Certifications

    • American Board of Psychiatry and Neurology

      Neurology
  • Teaching Interests

    Dr Galvin and his colleagues at the Comprehensive Center for Brain Health (CCBH) develop unique training opportunities for students, residents, fellows, staff, and faculty to gain training, knowledge, and expertise in brain health and neurodegenerative diseases and provide structured mentoring opportunities for early-stage investigators on their path to research independence. CCBH also is actively involved in training the next generation of clinicians and scientists and providing educational programming for the lay community. In the past 2 years, CCBH has conducted over 60 programs reaching over 4000 individuals.
  • Research Interests

    The Comprehensive Center for Brain Health (CCBH), part of the Department of Neurology at the University of Miami Miller School of Medicine, was created to provide a robust and collaborative infrastructure to study brain health and the risk of neurodegenerative diseases such as Mild Cognitive Impairment, Alzheimer’s Disease, Parkinson’s Disease, Lewy Body Dementia, Frontotemporal Degeneration, Vascular Cognitive Impairment, and Chronic Traumatic Encephalopathy. CCBH uses a transdisciplinary approach for our research projects and clinical care, combining the best practices of neurology, gerontology, cognitive neuroscience, nursing, social work, psychotherapy, integrative nutrition, mindfulness, lifestyle modification, physical therapy, public health, medical education, epidemiology, biochemistry, genetics, data science, and biostatistics. In addition to our NIH-funded research, CCBH has a comprehensive clinical arm to evaluate, diagnosis and treat individuals with all forms of cognitive impairment, providing a personalized and tailored approach to brain health with a focus of improving the healthspan for all our patients.

    The Healthy Brain Initiative (HBI) Project is at the heart of CCBH’s mission. Funded by multiple federal and private grants, HBI is a longitudinal study to deeply phenotype individuals, determine factors that contribute the cognitive resilience and healthy brain aging, examine factors that increase vulnerability and risk of neurodegenerative disease, and explore social and medical determinants of brain health in diverse populations including African Americans, Afro-Caribbeans, Hispanics, rural communities, American Indians, Native Hawaiians, and Pacific Islanders. The ultimate goal of HBI is to develop dementia prevention programs using a precision medicine-like approach with personalized tailored interventions by combining innovative implementation of culturally adapted health literacy assessments alongside comprehensive “phenotype-to-genotype” community-based healthcare research. HBI supports a number of affiliated studies in Lewy Body Dementia, Alzheimer's disease, and mild cognitive impairment, including pragmatic studies using electronic health records and patient-reported outcomes, qualitative research on health disparities and stigma, creation of novel plasma and behavior-based biomarkers of neurodegenerative disease, and testing novel therapeutics and diagnostics.
  • Publications

    Loading...

    No result found

      Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.

    Articles & News

    Clinical Trials

    Viewing 0 of 10 clinical trials.